THThandeka Hlongwa

Thandeka Hlongwa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Thandeka Hlongwa has a total of 2 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Computational Identification of Epigenetic Modulators From Artemisia afra Targeting PfHDAC1 as Potential Antimalarial Agents: In Silico and Machine Learning‐Based Virtual Screening Approach

    by Deli‐Bright N.T. Oku, Thandeka Hlongwa, Ramakwala Christinah Chokwe

    Plasmodium falciparum ( P. falciparum ) histone deacetylase 1 (PfHDAC1) plays a critical role in the blood‐stage development of malaria parasites and represents a promising epigenetic target for antimalarial drug discovery. Despite the success of artemisinin combination therapies in reducing the global malaria burden, multidrug resistance in P. falciparum is emerging worldwide. This clearly shows the urgent need for innovative antimalarials that can target multiple stages of the parasite. In this study, we employed an integrated machine learning‐based virtual screening and molecular docking approach to identify potential epigenetic inhibitors of PfHDAC1 from Artemisia afra ( A. afra ). Multiple machine learning models were developed using different sampling strategies, feature subset sizes (10, 30, and 50 features), and hyperparameter optimization schemes. Among these, a Random Forest classifier trained using the Synthetic Minority Over‐sampling Technique with 30 selected features demonstrated strong and consistent predictive performance across the evaluated metrics. Application of the optimized model to A. afra phytochemicals identified 14 epigenetic modifiers predicted as active, all of which exhibited zero Lipinski's Rule‐of‐Five violations and fell within the model's applicability domain, supporting their selection for molecular docking and further investigation. Molecular docking further provided insights into their predicted binding interactions with PfHDAC1 and their potential for further evaluation as antimalarial candidates.